231 related articles for article (PubMed ID: 25018062)
1. Thrombosis and hemostatic abnormalities in hematological malignancies.
Colombo R; Gallipoli P; Castelli R
Clin Lymphoma Myeloma Leuk; 2014 Dec; 14(6):441-50. PubMed ID: 25018062
[TBL] [Abstract][Full Text] [Related]
2. Hematologic malignancies and thrombosis.
Elice F; Rodeghiero F
Thromb Res; 2012 Mar; 129(3):360-6. PubMed ID: 22197450
[TBL] [Abstract][Full Text] [Related]
3. Thromboembolic complications in malignant haematological disorders.
Castelli R; Ferrari B; Cortelezzi A; Guariglia A
Curr Vasc Pharmacol; 2010 Jul; 8(4):482-94. PubMed ID: 19485900
[TBL] [Abstract][Full Text] [Related]
4. Intravascular clotting activation and bleeding in patients with hematologic malignancies.
Tallman MS; Kwaan HC
Rev Clin Exp Hematol; 2004 Jun; 8(1):E1. PubMed ID: 16029967
[TBL] [Abstract][Full Text] [Related]
5. Thrombosis in multiple myeloma.
Zangari M; Elice F; Fink L; Tricot G
Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
[TBL] [Abstract][Full Text] [Related]
6. Drug-related thrombosis in hematologic malignancies.
Nadir Y; Hoffman R; Brenner B
Rev Clin Exp Hematol; 2004 Jun; 8(1):E4. PubMed ID: 16029970
[TBL] [Abstract][Full Text] [Related]
7. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
Falanga A; Rickles FR
Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism incidence in hematologic malignancies.
Kekre N; Connors JM
Blood Rev; 2019 Jan; 33():24-32. PubMed ID: 30262170
[TBL] [Abstract][Full Text] [Related]
9. Management of thrombosis in patients with hematologic malignancies.
Piccioli A; Vianello F; Prandoni P
Curr Hematol Rep; 2002 Sep; 1(1):79-83. PubMed ID: 12901128
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis in children with hematologic malignancies.
Schobess R; Kempf-Bielack B; Schwabe D; Sträter R; Nowak-Göttl U
Rev Clin Exp Hematol; 2004 Jun; 8(1):E2. PubMed ID: 16029968
[TBL] [Abstract][Full Text] [Related]
11. Incidence and pathogenesis of thrombosis in hematologic malignancies.
Kwaan HC; Vicuna B
Semin Thromb Hemost; 2007 Jun; 33(4):303-12. PubMed ID: 17525887
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in the hematologic malignancies.
Falanga A; Marchetti M; Russo L
Curr Opin Oncol; 2012 Nov; 24(6):702-10. PubMed ID: 23014188
[TBL] [Abstract][Full Text] [Related]
13. Adverse effects on hemostatic function of drugs used in hematologic malignancies.
Zakarija A; Kwaan HC
Semin Thromb Hemost; 2007 Jun; 33(4):355-64. PubMed ID: 17525893
[TBL] [Abstract][Full Text] [Related]
14. [Thromboembolic events in malignant diseases].
Gadó K; Domján G
Orv Hetil; 2012 Jun; 153(24):934-47. PubMed ID: 22695629
[TBL] [Abstract][Full Text] [Related]
15. Thromboembolic risk in hematological malignancies.
Franchini M
Clin Chem Lab Med; 2015 Jul; 53(8):1139-47. PubMed ID: 25503466
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Prediction of Central Venous Catheter Related-Thrombosis in Patients With Hematological Malignancies.
Boersma RS; Hamulyak K; van Oerle R; Tuinenburg A; Ten Cate-Hoek AJ; Schouten HC
Clin Appl Thromb Hemost; 2016 Nov; 22(8):779-784. PubMed ID: 25888571
[TBL] [Abstract][Full Text] [Related]
17. Blood viscosity and thrombosis: clinical considerations.
Smith BD; La Celle PL
Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
[TBL] [Abstract][Full Text] [Related]
18. Anticancer treatment and thrombosis.
Falanga A; Marchetti M
Thromb Res; 2012 Mar; 129(3):353-9. PubMed ID: 22119391
[TBL] [Abstract][Full Text] [Related]
19. Bleeding and thrombosis in multiple myeloma and related plasma cell disorders.
Coppola A; Tufano A; Di Capua M; Franchini M
Semin Thromb Hemost; 2011 Nov; 37(8):929-45. PubMed ID: 22198858
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in the hematologic malignancies.
Falanga A; Marchetti M
J Clin Oncol; 2009 Oct; 27(29):4848-57. PubMed ID: 19752334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
